|
Intellectual
Property
Inspire
has an aggressive patent strategy and currently has approximately
76 issued patents that are either owned or licensed. In addition,
Inspire has various additional U.S. patents pending, and multiple
foreign patents issued and pending.
Inspire
Patents:
|
| 5,292,498 |
Method
of Treating Lung Disease with Uridine Triphosphates |
| 5,596,088 |
DNA
Encoding the Human P2u Receptor and Null Cells Expressing P2u
Receptor |
| 5,607,836 |
Methods
of Detecting Compounds Which Bind to the P2u Receptor |
| 5,628,984 |
Method
of Detecting Lung Disease |
| 5,635,160 |
Dinucleotides
Useful for the Treatment of Lung Disease |
| 5,691,156 |
DNA
Encoding the Human P2u Receptor and Null Cells Expressing P2u
Receptor |
| 5,763,447 |
Methods
of Preventing or Treating Pneumonia in Immobilized Patients
Using UTP and Related Compounds
|
| 5,789,391 |
Method
of Treating Sinusitis with UTP and Related Compounds
|
| 5,798,380 |
Cytoskeletal
Active Agents for Glaucoma Therapy |
| 5,837,861 |
Certain
Dinucleotides and Their Use as Modulators of Mucociliary Clearance
and Ciliary Beat Frequency |
| 5,900,407 |
Method
of Treating Dry Eye Disease with Purinergic Receptor Agonists
|
| 5,902,567 |
Method
of Detecting Lung Disease |
| 5,935,555 |
Dinucleotides
Useful for the Treatment of Lung Disease |
| 5,958,897 |
Method
of Treating Sinusitis with UTP and Related Compounds |
| 5,962,432 |
A
Sterilized Isotonic and pH-Adjusted Pharmaceutical Formulation
of Uridine Triphosphate |
| 5,968,913 |
Novel
Pharmaceutical Compositions of Uridine Triphosphate |
| 5,972,904 |
Method
of Treating Sinusitis with UTP and Related Compounds |
| 5,981,506 |
Method
of Treating Sinusitis with UTP and Related Compounds |
| 6,022,527 |
Method
of Treating Lung Diseases with Uridine 5'-Diphosphate and Analogs
Thereof |
| 6,110,912 |
Cytoskeletal
Active Agents for Glaucoma Therapy
|
| 6,133,247 |
Method
of Detecting Lung Disease |
| 6,143,279 |
Method
of Treating Lung Diseases with Uridine 5'-Diphosphate and Analogs
Thereof |
| 6,159,952 |
Method
of Treating Bronchitis with Uridine Triphosphate and Related
Compounds |
| 6,214,536 |
Method
of Detecting Lung Disease |
| 6,235,266 |
Dinucleotides
Useful for the Treatment of Lung Disease |
| 6,239,113 |
Topical
Treatment or Prevention of Ocular Infections |
| 6,277,855 |
Method
of Treating Dry Eye Disease with Nicotinic Acetylcholine Receptor
Agonists |
| 6,319,908 |
Method
For Large-Scale Production Of Di(Uridine 5'-Tetraphosphate)
and Salts Thereof |
| 6,323,187 |
Therapeutic
Dinucleotide and Derivatives (CP4U Tetraphosphate) |
| 6,331,529 |
Method
of Promoting Mucosal Hydration with Certain Uridine, Adenine
and Cytidine Diphosphates and Analogs Thereof |
| 6,348,589 |
Certain
Dinucleotides and Their Use as Modulators of Mucociliary Clearance
and Ciliary Beat Frequency |
| 6,420,347
|
Method
of Treating Ciliary Dyskinesia with Uridine Triphosphates and
Related Compounds |
| 6,423,694
|
Method
of Treating Otitis Media with Uridine Triphosphates and Related
Compounds |
| 6,436,910 |
Method
of Promoting Mucosal Hydration with Certain Uridine, Adenine
and Cytidine Diphosphates and Analogs Thereof |
| 6,448,276 |
Method
for Treating Vaginal Dryness with Nicotinic Actylcholine Receptor
Agonists
|
| 6,451,288 |
Method
of Treating Lung Diseases with Uridine 5'-diphosphate and Analogs
Thereof |
| 6,462,028 |
Method
of Promoting Cervical and Vaginal Secretions
|
| 6,548,658 |
Methods
for Large-Scale Production of Di-(Uridine 5')-Tetraphosphate
and Analogs Thereof |
| 6,555,675 |
Dinucleoside
Polyphosphate Compositions and Their Therapeutic Use as Purinergic
Receptor Agonists |
| 6,569,443 |
Topical
Treatment or Prevention of Ocular Infections |
| 6,586,425 |
Cytoskeletal
Active Agents for Glaucoma Therapy |
| 6,596,725 |
Use
of Certain Dinucleotides to Stimulate Removal of Fluid in Retinal
Detachment and Retinal Edema |
| 6,624,150 |
Method
of Treating Gastrointestinal Tract Disease with Purinergic Receptor
Agonists |
| 6,673,779 |
Method
of Treating Ciliary Dyskinesia with Dinucleoside Polyphosphate
Compounds |
| 6,696,425 |
Method
of Treating Dry Eye Disease With Purinergic Receptor Agonists |
| 6,703,376 |
Use
of Uridine Triphosphates and Related Compounds for the Prevention
and Treatment of Pneumonia in Immobilized Patients
|
| 6,713,458 |
Therapeutic
Uses of Di(Uridine 5')-Tetraphosphate and Salts Thereof |
| 6,765,090 |
Method
For Large-Scale Production of Di(Uridine 5')-Tetraphosphate
and Salts Thereof |
6,818,629
|
Pharmaceutical
Formulation Comprising P1-(2'-Deoxycytidine 5'-)P4-(Uridine
5'-) Tetraphosphate |
| 6,861,411 |
Method
of Treating Eye Infections with Azithromycin |
6,864,243
|
Method
for Treating Retinal Degeneration with Purinergic Receptor Agonists |
6,867,199
|
Dinucleoside
Polyphosphates Compositions and Their Therapeutic Use |
6,872,710
|
Di(Uridine
5')-Tetraphosphate and Salts Thereof |
6,881,725
|
Method
for Treating Pain |
6,887,858
|
Method
of Treating Dry Eye Disease With Purinergic Receptor Agonists |
6,897,201
|
Compositions
and Methods for the Treatment of Glaucoma or Ocular Hypertension |
6,916,794
|
Method
of Enhancing Drainage of Lacrimal System with Purinergic Receptor
Agonists |
6,921,755
|
Method
of Treating Dry Eye Disease With Purinergic Receptor Agonists |
| 6,977,246 |
Certain
Dinucleotides and Their Use as Modulators Of Mucociliary Clearance
And Ciliary Beat Frequency |
7,018,985
|
Composition
and Method for Inhibiting Platelet Aggregation |
| 7,056,893 |
Topical
Treatment for Prevention of Infections |
| 7,078,391 |
Method
of Treating Edematous Retinal Disorders |
| 7,084,128 |
Method
for Reducing Intraocular Pressure |
| 7,091,334 |
Method
For Large-Scale Production Of Di(Uridine 5’-Tetraphosphate)
and Salts Thereof |
| 7,101,860 |
Composition
and Method for Inhibiting Platelet Aggregaton |
| 7,109,181 |
Joint
Lubrication With P2Y Purinergic Receptor Agonists |
| 7,115,585 |
Compositions
For Treating Epithelial And Retinal Tissue Diseases |
| 7,132,408 |
Composition
and Method for Inhibiting Platelet Aggregation |
| 7,132,410 |
Di(Uridine
5'-)Tetraphosphate and Salts Thereof
|
|
7,223,744
|
Pharmaceutical
Formulation Comprising Dinucleoside Polyphosphates and Salts
Thereof
|
| 7,235,535 |
Method
of Enhancing Drainage of Lacrimal System with Purinergic Receptor
Agonists |
| 7,247,623 |
Method
of Treating Dry Eye Disease with Non-Drying Antihistamines |
| 7,256,183 |
Method
for Treating or Preventing Inflammatory Diseases |
| 7,320,974 |
Cytoskeletal
Active Compounds, Compositions and Use |
| 7,335,648 |
Non-Nucleotide
Composition and Method for Inhibiting Platelet Aggregation |
| 7,335,648 |
Non-Nucleotide
Composition and Method for Inhibiting Platelet Aggregation |
7,368,438
|
Non-Nucleotide
Composition and Method for Inhibiting Platelet Aggregation |
| |
Page
last updated: 08-May-2008
|
|
|
|
|
|
|
Copyright
© 1999-2005 Inspire Pharmaceuticals Inc. All rights reserved
|
|
|
|
